605177.SHG Zhejiang East Asia Pharmaceutical Co. Ltd.

Healthcare Pharmaceuticals Shanghai Stock Exchange
21.27 CNY
Close of Nov 5, 2026
13.71 28.29
Market cap
CNY 2.44B
P/E
-
P/B
1.35x
ROE
-13.9%
Dividend yield
0.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 605177.SHG undervalued?

Graham number

The Graham number of Zhejiang East Asia Pharmaceutical Co. Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang East Asia Pharmaceutical Co. Ltd. fundamental analysis

No fundamental analysis for Zhejiang East Asia Pharmaceutical Co. Ltd. yet.

Zhejiang East Asia Pharmaceutical Co. Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang East Asia Pharmaceutical Co. Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules in China and internationally. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic a…

Full company profile